印尼TelkomMetra同意将医疗单位AdMedika卖给新加坡Fullerton健康公司80-100M美元。 Indonesia’s TelkomMetra agrees to sell healthcare unit AdMedika to Singapore’s Fullerton Health for $80–100M.

印度尼西亚国有电信集团的TelkomMetra公司签署了一项有条件的协议,将其医疗保健部门AdMedika集团,包括TelkoMedika,出售给总部位于新加坡的富勒顿健康. TelkomMetra, a unit of Indonesia’s state-owned TelkomGroup, has signed a conditional agreement to sell its healthcare arm AdMedika Group, including TelkoMedika, to Singapore-based Fullerton Health. 这项交易于2026年3月4日宣布, 是Telkom精简其投资组合及关注核心数字和电信业务战略的一部分。 The deal, announced March 4, 2026, is part of Telkom’s strategy to streamline its portfolio and focus on core digital and telecom operations. AdMedika是印度尼西亚主要技术驱动的医疗保健管理员,他将过渡到Fullerton Health(Fullerton Health)的所有权,其目的是利用AdMedika(AdMedika)的平台和数字能力扩大其区域医疗保健足迹。 AdMedika, a leading tech-driven healthcare administrator in Indonesia, will transition to Fullerton Health’s ownership, which aims to expand its regional healthcare footprint using AdMedika’s platform and digital capabilities. 这笔价值8 000至1亿美元的交易须得到管理部门的批准和其他关闭条件。 The transaction, valued at $80–100 million, is subject to regulatory approval and other closing conditions.